ZENO

Zenosense Inc NV (CE) (ZENO)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:ZENO
DataOraFonteTitoloSimboloCompagnia
20/04/202218:39Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ZENOZenosense Inc NV (CE)
16/03/202215:50Edgar (US Regulatory)Annual Report (10-k)USOTC:ZENOZenosense Inc NV (CE)
16/03/202211:05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ZENOZenosense Inc NV (CE)
01/03/202217:41Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:ZENOZenosense Inc NV (CE)
01/04/201921:00Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ZENOZenosense Inc NV (CE)
02/10/201813:42InvestorsHub NewsWireZenosense, Inc.: MIDS Medical Expands Technical TeamUSOTC:ZENOZenosense Inc NV (CE)
05/09/201814:00InvestorsHub NewsWireZenosense, Inc.: MIDS Medical JV to Receive Funding of Up to $1.2 MillionUSOTC:ZENOZenosense Inc NV (CE)
14/08/201817:05Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ZENOZenosense Inc NV (CE)
26/06/201814:45InvestorWireDiagnostics Play Critical Role in Medical SectorUSOTC:ZENOZenosense Inc NV (CE)
19/06/201813:52InvestorsHub NewsWireZenosense, Inc.: Breakthrough Quantitative MIDS Testing ResultsUSOTC:ZENOZenosense Inc NV (CE)
16/11/201713:38InvestorsHub NewsWireZenosense, Inc.: MIDS Hybrid Strip - Successful Initial Test ResultsUSOTC:ZENOZenosense Inc NV (CE)
05/07/201713:54InvestorsHub NewsWireZenosense, Inc. - MIDS Hybrid Strip Detection Testing to CommenceUSOTC:ZENOZenosense Inc NV (CE)
15/06/201713:47InvestorsHub NewsWireZenosense, Inc.: Issuance of U.S. MIDS PatentUSOTC:ZENOZenosense Inc NV (CE)
19/05/201721:10Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:ZENOZenosense Inc NV (CE)
20/04/201715:00InvestorsHub NewsWireWhat Cannabis Stocks Investors Should Know and Coverage of a Mobile Tech Sub Penny StockUSOTC:ZENOZenosense Inc NV (CE)
28/03/201715:15InvestorsHub NewsWireZenosense, Inc.: MIDS Medical Engages Future Diagnostics for Assay Consulting ServicesUSOTC:ZENOZenosense Inc NV (CE)
10/03/201713:36InvestorsHub NewsWireZenosense, Inc.: MIDS Quantitative Testing ResultsUSOTC:ZENOZenosense Inc NV (CE)
06/02/201721:10Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:ZENOZenosense Inc NV (CE)
23/01/201714:47InvestorsHub NewsWireZenosense, Inc.: New Patent Application for Additional MIDS Detection MethodUSOTC:ZENOZenosense Inc NV (CE)
17/11/201616:00InvestorsHub NewsWireZenosense, Inc. MIDS Proof of Market ReportUSOTC:ZENOZenosense Inc NV (CE)
29/06/201621:44Edgar (US Regulatory)Information Statement - All Other (definitive) (def 14c)USOTC:ZENOZenosense Inc NV (CE)
17/06/201622:45Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)USOTC:ZENOZenosense Inc NV (CE)
16/06/201623:11Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:ZENOZenosense Inc NV (CE)
16/06/201620:51Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ZENOZenosense Inc NV (CE)
17/12/201414:50InvestorsHub NewsWireZenosense, Inc. - Hospital Collaboration - 400 Person Lung Cancer Detection TrialUSOTC:ZENOZenosense Inc NV (CE)
27/10/201414:00eTeligisZenosense, Inc.; MRSA/SA Prototype Achieves over 95% Sensibility in Cultured HeadspaceUSOTC:ZENOZenosense Inc NV (CE)
27/05/201414:30MarketwiredZenosense, Inc. Highlights Recent Media Coverage of MRSAUSOTC:ZENOZenosense Inc NV (CE)
21/05/201414:30MarketwiredZenosense, Inc. Provides Development UpdateUSOTC:ZENOZenosense Inc NV (CE)
08/05/201414:30MarketwiredZenosense, Inc. Extends License to Include Cancer ApplicationsUSOTC:ZENOZenosense Inc NV (CE)
10/04/201415:27MarketwiredZenosense, Inc. Enters Into $475,000 Securities Purchase AgreementUSOTC:ZENOZenosense Inc NV (CE)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:ZENO
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network